Sysmex Corporation (TYO:6869)
Japan
· Delayed Price · Currency is JPY 1,999.50
+5.50 (0.28%)
Aug 15, 2025, 3:30 PM JST
Sysmex Revenue
Sysmex had revenue of 105.73B JPY in the quarter ending June 30, 2025, a decrease of -5.55%. This brings the company's revenue in the last twelve months to 502.43B, up 5.09% year-over-year. In the fiscal year ending March 31, 2025, Sysmex had annual revenue of 508.64B with 10.21% growth.
Revenue (ttm)
502.43B
Revenue Growth
+5.09%
P/S Ratio
2.48
Revenue / Employee
47.70M
Employees
10,533
Market Cap
1,246.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 508.64B | 47.13B | 10.21% |
| Mar 31, 2024 | 461.51B | 51.01B | 12.43% |
| Mar 31, 2023 | 410.50B | 46.72B | 12.84% |
| Mar 31, 2022 | 363.78B | 58.71B | 19.24% |
| Mar 31, 2021 | 305.07B | 3.09B | 1.02% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |
Sysmex News
- 8 days ago - Sysmex Corporation (SSMXY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Sysmex reports FQ1 results - Seeking Alpha
- 3 months ago - Sysmex GAAP EPS of Yen 86.05, revenue of Yen 508.6B - Seeking Alpha
- 6 months ago - Sysmex reports 9M results - Seeking Alpha
- 10 months ago - Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B - Seeking Alpha